First-In-Human (FIH) Trial Evaluating the Safety and Tolerability of Single and Multiple Ascending Oral Doses of IRL757 in Healthy Volunteers
Clinical trial NCT06493045 · COMPLETED
Trial details
- NCT number
- NCT06493045
- Sponsor
- Integrative Research Laboratories AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-16
- Primary completion
- 2025-02-07
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.